| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/25/2008 | US20080317837 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 12/25/2008 | US20080317835 Personalized Nutrient Deficiency Assay Methods |
| 12/25/2008 | US20080317834 Compounds and methods for modulating cerebral amyloid angiopathy |
| 12/25/2008 | US20080317826 Porous keratin constructs, wound healing assemblies and methods using the same |
| 12/25/2008 | US20080317822 Methods for Delivery of Nanosome Encapsulated Agents |
| 12/25/2008 | US20080317816 Porous objects having immobilized encapsulated biomolecules |
| 12/25/2008 | US20080317812 Spacer with a coating thereon for use with an implant device |
| 12/25/2008 | US20080317810 Methods and Compositions for Reducing Oxalate Concentrations |
| 12/25/2008 | US20080317809 Use of K -252a and Kinase Inhibitors for the Prevention or Treatment of Hmgb1-Associated Pathologies |
| 12/25/2008 | US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317779 Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof |
| 12/25/2008 | US20080317773 Conjugates that contain the homeodomain of antennapedia |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317763 Regulation of Metalloprotease Cleavage of Cell Surface Proteins |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317756 Antibodies to Chemokine Alpha-5 |
| 12/25/2008 | US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317753 Selecting patients for therapy with a her inhibitor |
| 12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 12/25/2008 | US20080317740 Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells |
| 12/25/2008 | US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction |
| 12/25/2008 | US20080317737 Drug combination for the treatment of skin disorders |
| 12/25/2008 | US20080317736 Methods for enlarging the diameter of a biological conduit in a human subject |
| 12/25/2008 | US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 12/25/2008 | US20080317734 Nutraceutical compositions and methods with biologically active ingredients |
| 12/25/2008 | US20080317733 Cosmeceutical Compositions and Methods with Biologically Active Ingredients |
| 12/25/2008 | US20080317732 Amyloid Peptide Inactivating Enzyme to Treat Alzheimer's Disease Peripherally |
| 12/25/2008 | US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 12/25/2008 | US20080317730 Compositions Useful for Recovering Original Trophism and Pigmentation, and for Stimulating Growth of the Integumentary Apparatus, Uses and Products Thereof |
| 12/25/2008 | US20080317729 Ammonium Salts and Ammonium Salt/Mineral Salt Clathrate Compounds for Use as Vehicle and Effective Form for Pharmaco-Medical Applications and for Use as Phase Transfer Agents for Chemical Applications |
| 12/25/2008 | US20080317728 Lowering Uric Acid to Prevent or Accelerate Recovery of Acute Renal Failure |
| 12/25/2008 | US20080317727 Method of skin treatment for rosacea using epidermal growth factor |
| 12/25/2008 | US20080317726 Proteases for Pharmaceutical Use |
| 12/25/2008 | US20080317725 Compositions and methods of treating chronic kidney disease |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/25/2008 | US20080317714 Method of Treating Hepatitis B Viral Infection |
| 12/25/2008 | US20080317713 Derivatives of growth hormone and related proteins |
| 12/25/2008 | US20080317712 Arylpiperidinyl and arylpyrrolidinyl tripeptide hepatitis c serine protease inhibitors |
| 12/25/2008 | US20080317711 Treatment of Optic Neuritis |
| 12/25/2008 | US20080317710 Methods For Treating Autoimmune or Demyelinating Diseases |
| 12/25/2008 | US20080317709 Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 12/25/2008 | US20080317708 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3dione |
| 12/25/2008 | US20080317707 Pegylated interleukin-10 |
| 12/25/2008 | US20080317706 Targeted Conjugates and Radiation |
| 12/25/2008 | US20080317705 Promoting Wound Healing by Administering a Prostaglandin E and Granulocyte-Macrophage Colony Stimulating Factor |
| 12/25/2008 | US20080317690 Dermatological or oral disease; drug delivery; sustained release; onychomycosis; contains benzoin, a topical active agent and a volatile solvent like ethanol |
| 12/25/2008 | US20080317670 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 12/25/2008 | US20080317669 Cloning of honey bee allergen C |
| 12/25/2008 | US20080317668 Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications |
| 12/25/2008 | US20080317667 Compositions and methods for inhibiting growth of smad4-deficient cancers |
| 12/25/2008 | US20080314333 Animal chew toy containing solid food |
| 12/24/2008 | WO2008157840A2 Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration |
| 12/24/2008 | WO2008157776A2 Modified diphtheria toxins |
| 12/24/2008 | WO2008157753A1 Methods of treatment for spinal muscular atrophy |
| 12/24/2008 | WO2008157747A1 Use of inhibition of exonuclease 1 in methods for therapy and diagnostic of neurodegenerative diseases, eye diseases, and mitochondrial disorders |
| 12/24/2008 | WO2008157593A2 Protein c for use in maintaining hemostasis |
| 12/24/2008 | WO2008157483A2 Polypeptides and methods of use |
| 12/24/2008 | WO2008157425A2 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 12/24/2008 | WO2008157419A2 Immunogenic peptides of influenza virus |
| 12/24/2008 | WO2008157367A1 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor |
| 12/24/2008 | WO2008157302A2 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| 12/24/2008 | WO2008156873A2 Apoa-1 peptide mimetics |
| 12/24/2008 | WO2008156725A2 Methods for inhibiting cartilage mineralization |
| 12/24/2008 | WO2008156699A1 Targeted oxygen delivery via intravenous or intra-arterial infusion of oxygenated polymerized hemoglobin solutions |
| 12/24/2008 | WO2008156677A2 Cyclic peptide melanocortin receptor ligands |
| 12/24/2008 | WO2008156676A1 Methods and compositions for detecting and modulating o-glycosylation |
| 12/24/2008 | WO2008156645A2 Pharmaceutical compositions and uses |
| 12/24/2008 | WO2008156428A2 Novel peptides and protein and uses thereof |
| 12/24/2008 | WO2008156363A1 Selective inhibitors of the nuclear factor of activated t-cells |
| 12/24/2008 | WO2008156356A1 Preparation of a pharmaceutically active ingredient comprising a desolventising step |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155900A1 Glp-1 peptide having sugar chain attached thereto |
| 12/24/2008 | WO2008155509A2 Modified human factor vii/viia and pharmaceutical composition containing same |
| 12/24/2008 | WO2008155467A1 Transmembrane prostatic acid phosphatase |
| 12/24/2008 | WO2008155403A2 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases |
| 12/24/2008 | WO2008155134A1 Biological active proteins having increased in vivo and/or vitro stability |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008154813A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 12/24/2008 | WO2008154753A1 Method for measuring the response of a tissue to an electromagnetic field |
| 12/24/2008 | WO2008154738A1 Azapeptides as cd36 binding compounds |
| 12/24/2008 | WO2008154719A1 Recombinant human interferon-like proteins |
| 12/24/2008 | WO2008154700A1 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
| 12/24/2008 | WO2008138001A3 Synthetic peptides and peptide mimetics |
| 12/24/2008 | WO2008137901A3 Methods for treating and preventing gi syndrome and graft versus host disease |
| 12/24/2008 | WO2008134767A3 Methods for treating and preventing multiple sclerosis |
| 12/24/2008 | WO2008134752A3 Methods and compositions for the treatment of cancer |
| 12/24/2008 | WO2008134464A3 Sample-processing reagent compositions, methods, and devices |
| 12/24/2008 | WO2008133928A3 Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders |
| 12/24/2008 | WO2008133789A3 Methods and compositions for targeting afap |
| 12/24/2008 | WO2008133704A3 Antimicrobial and antiviral compounds and methods for their use |
| 12/24/2008 | WO2008131002A3 Generation of acyl amino acids |
| 12/24/2008 | WO2008130591A3 Using trefoil polypeptides to treat eye lesions associated with ophthalmic procedures |
| 12/24/2008 | WO2008124698A3 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 12/24/2008 | WO2008124173A8 Combination therapy for cardiac revascularization and cardiac repair |
| 12/24/2008 | WO2008124086A3 Chimeric activators: quantitatively designed protein therapeutics and uses thereof |
| 12/24/2008 | WO2008115390A3 Methods of using defensins to treat diabetes |
| 12/24/2008 | WO2008112840A3 Novel composition and methods for the treatment of immune related diseases |